Not Yet Recruiting
Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma
NCT07414979
- Conditions
- Leptomeningeal Melanoma
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States